journal
MENU ▼
Read by QxMD icon Read
search

JACC. Clinical Electrophysiology

journal
https://read.qxmd.com/read/30784704/it-is-time-for-us-to-get-artificially-intelligent
#1
EDITORIAL
Jagmeet P Singh
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784703/incessant-idiopathic-ventricular-fibrillation-trigger-originating-from-an-unusual-intramyocardial-non-purkinje-site-successfully-treated-with-catheter-ablation
#2
Robert D Anderson, Cuneyt Ada, Geoffrey Lee, Jonathan M Kalman, Jitendra K Vohra, Saurabh Kumar
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784702/his-bundle-pacing-post-atrioventricular-node-ablation-mapping-his-bundle-potential-from-down-under
#3
Dominik Linz, Bradley Pitman, Kadhim Kadhim, Catherine O'Shea, Rajiv Mahajan, Prashanthan Sanders, Dennis H Lau
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784701/his-bundle-pacing-a-look-inside-the-beating-heart
#4
Aditya Saini, Vigneshwar Kasirajan, Jayanthi Koneru, Kenneth A Ellenbogen
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784700/one-size-doesn-t-fit-all-individualized-left-ventricular-lead-implantation-in-cardiac-resynchronization-therapy-patients
#5
LETTER
Sohaib Haseeb, Enes Elvin Gul
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784699/sudden-death-can-be-the-first-manifestation-of-hypertrophic-cardiomyopathy-data-from-a-united-kingdom-pathology-registry
#6
LETTER
Gherardo Finocchiaro, Michael Papadakis, Gaia Tanzarella, Harshil Dhutia, Chris Miles, Maite Tome, Elijah R Behr, Sanjay Sharma, Mary N Sheppard
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784698/the-real-world-utility-of-the-linq-implantable-loop-recorder-in-pediatric-and-adult-congenital-heart-patients
#7
Vassilios J Bezzerides, Amy Walsh, Maria Martuscello, Carolina A Escudero, Kimberlee Gauvreau, Geralyn Lam, Dominic J Abrams, John K Triedman, Mark E Alexander, Laura Bevilacqua, Douglas Y Mah
OBJECTIVES: This study sought to determine the practical use of the recently introduced LINQ implantable loop recorder (LINQ-ILR) in a cohort of pediatric and adult congenital arrhythmia patients. BACKGROUND: Correlating symptoms to a causative arrhythmia is a key aspect of diagnosis and management in clinical electrophysiology. METHODS: Retrospective review of clinical data, implantation indications, findings, and therapeutic decisions in patients who underwent LINQ-ILR implantation from April 1st, 2014 to January 30th, 2017 at Boston Children's Hospital...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784697/antiarrhythmic-drugs-for-atrial-fibrillation-in-the-real-world-trick-or-treat
#8
EDITORIAL
Gerald V Naccarelli
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784696/real-world-comparison-of-classes-ic-and-iii-antiarrhythmic-drugs-as-an-initial-rhythm-control-strategy-in-newly-diagnosed-atrial-fibrillation-from-the-treat-af-study
#9
Ryan Kipp, Mariam Askari, Jun Fan, Michael E Field, Mintu P Turakhia
OBJECTIVES: In this study the authors investigated effectiveness and safety of an initial treatment strategy with class IC or class III antiarrhythmic drugs (AAD) for newly diagnosed atrial fibrillation (AF) or atrial flutter (AFL). BACKGROUND: There is limited evidence to guide optimal AAD selection for rhythm control in newly diagnosed AF/AFL. METHODS: Using data from TREAT-AF (The Retrospective Evaluation and Assessment of Therapies in AF), the authors performed a retrospective cohort study of patients with AF/AFL from 2004 to 2014 and class IC or class III AAD prescription within 90 days following diagnosis...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784695/exclusion-of-intra-atrial-thrombus-diagnosis-using-d-dimer-assay-before-catheter-ablation-of-atrial-fibrillation
#10
Antoine Milhem, Pierre Ingrand, Frédéric Tréguer, Olivier Cesari, Antoine Da Costa, Dominique Pavin, Philippe Rivat, Nicolas Badenco, Sélim Abbey, Noura Zannad, Pierre François Winum, Jacques Mansourati, Philippe Maury, Hugues Bader, Arnaud Savouré, Frédéric Sacher, Marius Andronache, Caroline Allix-Béguec, Christian De Chillou, Frédéric Anselme
OBJECTIVES: This study hypothesized that the association of D-dimer blood level and several clinical items in a new risk score could predict the absence of atrial thrombus. BACKGROUND: Symptomatic and drug resistant atrial fibrillation (AF) can be treated by catheter ablation. The procedure-related risk of thromboembolism is limited by the pre-operative use of transesophageal echocardiography (TEE) to detect atrial thrombi. METHODS: Patients admitted for catheter ablation of AF (n = 2,494) were prospectively included in a multicenter study...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784694/flecainide-to-unmask-infranodal-disease-a-better-sieve
#11
EDITORIAL
Yash Lokhandwala, Binay Kumar
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784693/flecainide-versus-procainamide-in-electrophysiological-study-in-patients-with-syncope-and-wide-qrs-duration
#12
Ivo Roca-Luque, Jaume Francisco-Pasqual, Gerard Oristrell, Julián Rodríguez-García, Alba Santos-Ortega, Gabriel Martin-Sanchez, Nuria Rivas-Gandara, Jordi Perez-Rodon, Ignacio Ferreira-Gonzalez, David García-Dorado, Angel Moya-Mitjans
OBJECTIVES: This study sought to compare the differences between procainamide and flecainide to stress the His-Purkinje system during electrophysiological study (EPS) in patients with syncope and bundle branch block (BBB). BACKGROUND: Patients with syncope and BBB are at risk of developing atrioventricular block. EPS is recommended including class I drug challenge to unmask His-Purkinje disease in cases with baseline normal His-ventricular interval. There is little data on differences between different class I drugs...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784692/smart-about-watches-we-need-technical-and-biological-validation-of-atrial-fibrillation-screening
#13
EDITORIAL
Manish Kalla, Larissa Fabritz, Paulus Kirchhof
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784691/the-watch-af-trial-smartwatches-for-detection-of-atrial-fibrillation
#14
Marcus Dörr, Vivien Nohturfft, Noé Brasier, Emil Bosshard, Aleksandar Djurdjevic, Stefan Gross, Christina J Raichle, Mattias Rhinisperger, Raphael Stöckli, Jens Eckstein
OBJECTIVES: The WATCH AF (SmartWATCHes for Detection of Atrial Fibrillation) trial compared the diagnostic accuracy to detect atrial fibrillation (AF) by a smartwatch-based algorithm using photoplethysmographic (PPG) signals with cardiologists' diagnosis by electrocardiography (ECG). BACKGROUND: Timely detection of AF is crucial for stroke prevention. METHODS: In this prospective, 2-center, case-control trial, a PPG pulse wave recording using a commercially available smartwatch was obtained along with Internet-enabled mobile ECG in 672 hospitalized subjects...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784690/a-substernal-defibrillator-lead-with-pacing-capability-another-tool-in-the-toolbox
#15
EDITORIAL
Joshua E Payne, Michael R Gold
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784689/therapy-from-a-novel-substernal-lead-the-asd2-study
#16
Lucas V A Boersma, Béla Merkely, Petr Neuzil, Ian G Crozier, Devender N Akula, Liesbeth Timmers, Zbigniew Kalarus, Lou Sherfesee, Paul J DeGroot, Amy E Thompson, Daniel R Lexcen, Bradley P Knight
OBJECTIVES: The ASD2 (Acute Extravascular Defibrillation, Pacing, and Electrogram) study evaluated the ability to adequately sense, pace, and defibrillate patients with a novel implantable cardioverter-defibrillator (ICD) lead implanted in the substernal space. BACKGROUND: Subcutaneous ICDs are an alternative to a transvenous defibrillator system when transvenous implantation is not possible or desired. An alternative extravascular system placing a lead under the sternum has the potential to reduce defibrillation energy and the ability to deliver pacing therapies...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784688/home-and-alone-not-with-lead-extraction
#17
EDITORIAL
Nigel Lever, Andrew Martin
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784687/efficacy-and-safety-of-transvenous-lead-extraction-in-the-device-laboratory-and-operating-room-guided-by-a-novel-risk-stratification-scheme
#18
Krishna Kancharla, Nancy G Acker, Zhuo Li, Swetha Samineni, Cheng Cai, Raul E Espinosa, Michael Osborn, Siva K Mulpuru, Samuel J Asirvatham, Paul A Friedman, Yong-Mei Cha
OBJECTIVES: The goal of this study was to evaluate a novel risk stratification scheme to categorize patients on the basis of risk to either an operating room or device laboratory with rescue strategy. BACKGROUND: Lead extraction can be complicated by lethal issues such as vascular and cardiac rupture. Currently, the optimal site for lead extraction has not been well established. METHODS: A risk stratification scheme was developed from previously available risk factors for major complications...
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784686/leadless-pacing-in-hemodialysis-patients
#19
EDITORIAL
Joseph B Morton, Michael C G Wong
No abstract text is available yet for this article.
February 2019: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/30784685/leadless-pacemaker-implantation-in-hemodialysis-patients-experience-with-the-micra-transcatheter-pacemaker
#20
Mikhael F El-Chami, Nicolas Clementy, Christophe Garweg, Razali Omar, Gabor Z Duray, Charles C Gornick, Francisco Leyva, Venkata Sagi, Jonathan P Piccini, Kyoko Soejima, Kurt Stromberg, Paul R Roberts
OBJECTIVES: This study sought to report periprocedural outcomes and intermediate-term follow-up of hemodialysis patients undergoing Micra implantation. BACKGROUND: Leadless pacemakers may be preferred in patients with limited vascular access and high-infection risk, such as patients on hemodialysis. METHODS: Patients on hemodialysis at the time of Micra implantation attempt (n = 201 of 2,819; 7%) from the Micra Transcatheter Pacing Study investigational device exemption trial, Micra Transcatheter Pacing System Continued Access Study Protocol, and Micra Transcatheter Pacing System Post-Approval Registry were included in the analysis...
February 2019: JACC. Clinical Electrophysiology
journal
journal
50157
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"